pancreatic cancer
Immunovia, JW BioScience Ink Licensing Agreement for Early Pancreatic Cancer Detection Biomarkers
Immunovia said that it has secured intellectual property rights to the biomarkers, which are part of the diagnostic signature for its Immray PanCan-d blood test.
Konica Minolta Joins Precede Consortium to Improve Diagnosis and Treatment of Pancreatic Cancer
The company will employ its Lattice platform to shepherd and translate genomic and other data toward the development of new early diagnostics and interventions.
Bluestar Genomics Raises $70M in Series C Funding Round
The San Diego-based early cancer detection firm has also appointed Felix Fang and Craig Venter to its scientific advisory board.
BostonGene, Medical College of Wisconsin Partner on Pancreatic Cancer Biomarker Research
The partners will look for patterns in patients' exome sequencing and transcriptomics data to try to predict treatment response.
The firm said that recent validation studies have shown that a positive result with its PanCan-d microarray test could accelerate diagnosis for high-risk individuals.
Mar 1, 2021
Jun 11, 2020
Seven Bridges Building Research Platform for PanCAN
May 29, 2020
Tumor Microbiome Appears to Vary With Cancer Type
Apr 16, 2020